Can D0606 be used for routine screenings?

D0606 is typically used in specific clinical scenarios related to public health concerns, rather than routine screenings, unless the patient is in a high-risk category.

What types of specimens are used for D0606 testing?

Common specimens include saliva or nasal swabs, which are analyzed using molecular techniques to detect pathogens.

How should results from D0606 be documented?

Results should be documented in the patient's record, including the type of test, results, and any follow-up actions taken based on those results.

Are there any special considerations for billing D0606 during a pandemic?

During a pandemic, there may be special billing guidelines or waivers in place. It's important to stay updated with insurance policies and government regulations.

D0606

Molecular Testing for Pathogens - CDT Code Guide

Diagnostic/Tests and Examinations

Overview

CDT Code D0606 refers to molecular testing for public health-related pathogens, including coronavirus. This diagnostic procedure is crucial in identifying infectious agents that may pose a public health risk. The test involves collecting samples, such as saliva or nasal swabs, and analyzing them using molecular techniques to detect the presence of specific pathogens. This code is particularly relevant in the context of pandemics or outbreaks where rapid and accurate pathogen identification is essential for controlling the spread of disease. Dental professionals may encounter situations where this testing is necessary to ensure the safety of both patients and staff, especially in cases where a patient presents with symptoms consistent with a contagious illness.

When to Use This Code

When a patient presents with symptoms of a contagious disease during a dental visit
In the event of a local outbreak of a public health-related pathogen
Before performing aerosol-generating procedures on a patient with unknown health status
To ensure the safety of dental staff and other patients in the clinic
As part of a routine screening in high-risk populations

Documentation Requirements

Detailed patient history and presenting symptoms
Reason for ordering the molecular test
Type of specimen collected and collection method
Results of the molecular test
Follow-up actions based on test results

Billing Considerations

When billing for D0606, it is important to note any frequency limitations imposed by insurance providers, as well as the necessity of using appropriate modifiers to indicate the context of the test. Insurance coverage may vary, especially in non-pandemic times, so verifying patient benefits is crucial. Additionally, some insurers may require pre-authorization for this type of testing.

Related CDT Codes

D0150 D0180 D0191 D0415 D0416

Frequently Asked Questions

Coverage for D0606 varies by insurance provider and may depend on the current public health situation. It's important to verify benefits with the patient's insurer.

Need help with dental coding?

Our AI-powered assistant can answer your CDT code questions instantly.

Try CDT Code Lookup Browse All CDT Codes